---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-060245"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T13:51:50.359416+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Inogen Q3 revenue $84.0M, down 20.3% YoY; GAAP net loss $45.7M from $32.9M impairment

## Summary
- Total revenue $84.0M vs $105.4M in Q3 2022, down 20.3% YoY.
- GAAP net loss $45.7M vs $9.5M loss YoY; includes $32.9M non-cash impairment.
- Adjusted net loss $8.5M vs $4.1M loss; Adjusted EBITDA loss $5.5M vs $1.2M loss.
- Completed acquisition of Physio-Assist SAS, adding airway clearance portfolio.
- Cash $138.0M, no debt; focusing on returning to revenue growth.

## SEC filing metadata
- accession: 0000950170-23-060245
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/0000950170-23-060245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/ingn-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-060245
- JSON: https://secwatch.observer/filing/0000950170-23-060245.json
- Plain text: https://secwatch.observer/filing/0000950170-23-060245.txt

## Key facts
- Earnings Releases
  Inogen Inc reported the quarter ended September 30, 2023 results: revenue $84.0 million, net income GAAP net loss of $45.7 million.
  - Period: the quarter ended September 30, 2023
  - Revenue: $84.0 million
  - Net income: GAAP net loss of $45.7 million
  - Result: reported results
  source text: the homecare setting, today announced financial results for the quarter ended September 30, 2023. Third Quarter 2023 and Recent Business Highlights • Reported total revenue of $84.0 million, reflecting a decrease of 20.3% from the third quarter of 2022. • Completed acquisition of Physio-Assist SAS, expanding Inogen’s global respiratory care presence by addressing a
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/0000950170-23-060245-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.